Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Rutgers

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)A G J van Rossum, M Kok, E van Werkhoven, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)A G J van Rossum, M Kok, E van Werkhoven, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Pageof 8